Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer
| Image |  |
|---|---|
| Description | scientific article published on 24 October 2019 |
| Author/s |
author: Philip Jermann Ilaria Alborelli Laura P Leuenberger Katharina Leonards |
| Publication date | October 24, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |